Adapted from an article entitled, “¿ Effects of Cancer upoiz High-Density and Other Lipoproteins,― CANCER RESEARCH 30: 2420-2430, 1970. Dr. Barclay is Associate Me,nber, Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, Walker Laboratory, Rye, New York. Dr. Skipski is Associate Member, Division of Experimental Chemotherapy, Sloan Kettering Institute for Cancer Research, Walker Laboratory. Miss Terebus-Kekislz is Research Assista,zt, Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, Walker Laboratory. Mr. Greene is a volunteer, Sloan-Kettering Institute for Cancer Research, Walker Laboratory. Dr. Kaufmamz is Associate A ttending Physician, Department of Medicine, Memorial Hospital for Cancer and Allied Diseases, New York, New York. Dr. Stock is Vice President and Acting Deputy Director, Walker Laboratory. ABBREVIATIONS VLDL: Very-low-density lipoproteins with density less than 1 .006 g/mnl. LDL: Low-density lipoproteins with density less than 1.063 g/ ml. HDL: High-density lipoproteins. HDL: A component of the LDL, designated as S1 3-0. Coin ponents of the fraction with densities less than 1.125 g/mnl are HDL@: [(S1 4-0) the main component, S1 12-4 and 20-12 are the less dense components in this fractiomz]: HDL: High-density lipoproteins wit/i density less thami 1.21 g/mnl.
[1]
R. Levy,et al.
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques.
,
1968,
The Journal of clinical investigation.
[2]
V. P. Skipski,et al.
SERUM LIPOPROTEINS AND HUMAN NEOPLASTIC DISEASE.
,
1964,
Clinica chimica acta; international journal of clinical chemistry.
[3]
M. Barclay,et al.
The relation between plasma lipoproteins and breast carcinoma: Effect of degrees of breast disease on plasma lipoproteins and the possible role of lipid metabolic aberrations
,
1959,
Cancer.
[4]
B. Miller,et al.
The serum proteins and lipoproteins in patients with carcinoma and in subjects free of recurrence.
,
1956,
Surgery, gynecology & obstetrics.
[5]
J. Gofman,et al.
Ultracentrifugal studies of high density serum lipoproteins in clinically healthy adults.
,
1954,
The American journal of physiology.
[6]
J. Kellen.
The serum beta-lipoproteins in different human malignant diseases.
,
1968,
Neoplasma.
[7]
A. Nichols.
Human serum lipoproteins and their interrelationships.
,
1967,
Advances in biological and medical physics.
[8]
R. Lees,et al.
Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.
,
1967,
The New England journal of medicine.